Global Influenza Vaccination Market 2022 by Company, Regions, Type and Application, Forecast to 2028
The Influenza Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Influenza Vaccination market size is estimated to be worth US$ 3603 million in 2021 and is forecast to a readjusted size of USD 4927.3 million by 2028 with a CAGR of 4.6% during review period. Hospitals accounting for % of the Influenza Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Egg Based segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Influenza Vaccination include Abbott (U.S.), AstraZeneca (Europe), BioCryst Pharmaceuticals (U.S.), Novartis (Europe), and DAIICHI SANKYO COMPANY (Asia Pacific), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Influenza Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Egg Based
Cell Culture
Recombinant
Market segment by Application, can be divided into
Hospitals
Research Organizations
Market segment by players, this report covers
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals (U.S.)
Novartis (Europe)
DAIICHI SANKYO COMPANY (Asia Pacific)
GlaxoSmithKline (Europe)
Hualan Biological Engineering (Asia Pacific)
Mitsubishi Tanabe Pharma (Asia Pacific)
F. Hoffmann-La Roche (Europe)
Sanofi (Europe)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Influenza Vaccination product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Influenza Vaccination, with revenue, gross margin and global market share of Influenza Vaccination from 2019 to 2022.
Chapter 3, the Influenza Vaccination competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Influenza Vaccination market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Influenza Vaccination research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Influenza Vaccination
1.2 Classification of Influenza Vaccination by Type
1.2.1 Overview: Global Influenza Vaccination Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Influenza Vaccination Revenue Market Share by Type in 2021
1.2.3 Egg Based
1.2.4 Cell Culture
1.2.5 Recombinant
1.3 Global Influenza Vaccination Market by Application
1.3.1 Overview: Global Influenza Vaccination Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Research Organizations
1.4 Global Influenza Vaccination Market Size & Forecast
1.5 Global Influenza Vaccination Market Size and Forecast by Region
1.5.1 Global Influenza Vaccination Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Influenza Vaccination Market Size by Region, (2017-2022)
1.5.3 North America Influenza Vaccination Market Size and Prospect (2017-2028)
1.5.4 Europe Influenza Vaccination Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Influenza Vaccination Market Size and Prospect (2017-2028)
1.5.6 South America Influenza Vaccination Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Influenza Vaccination Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Influenza Vaccination Market Drivers
1.6.2 Influenza Vaccination Market Restraints
1.6.3 Influenza Vaccination Trends Analysis
2 Company Profiles
2.1 Abbott (U.S.)
2.1.1 Abbott (U.S.) Details
2.1.2 Abbott (U.S.) Major Business
2.1.3 Abbott (U.S.) Influenza Vaccination Product and Solutions
2.1.4 Abbott (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott (U.S.) Recent Developments and Future Plans
2.2 AstraZeneca (Europe)
2.2.1 AstraZeneca (Europe) Details
2.2.2 AstraZeneca (Europe) Major Business
2.2.3 AstraZeneca (Europe) Influenza Vaccination Product and Solutions
2.2.4 AstraZeneca (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AstraZeneca (Europe) Recent Developments and Future Plans
2.3 BioCryst Pharmaceuticals (U.S.)
2.3.1 BioCryst Pharmaceuticals (U.S.) Details
2.3.2 BioCryst Pharmaceuticals (U.S.) Major Business
2.3.3 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product and Solutions
2.3.4 BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 BioCryst Pharmaceuticals (U.S.) Recent Developments and Future Plans
2.4 Novartis (Europe)
2.4.1 Novartis (Europe) Details
2.4.2 Novartis (Europe) Major Business
2.4.3 Novartis (Europe) Influenza Vaccination Product and Solutions
2.4.4 Novartis (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Novartis (Europe) Recent Developments and Future Plans
2.5 DAIICHI SANKYO COMPANY (Asia Pacific)
2.5.1 DAIICHI SANKYO COMPANY (Asia Pacific) Details
2.5.2 DAIICHI SANKYO COMPANY (Asia Pacific) Major Business
2.5.3 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product and Solutions
2.5.4 DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments and Future Plans
2.6 GlaxoSmithKline (Europe)
2.6.1 GlaxoSmithKline (Europe) Details
2.6.2 GlaxoSmithKline (Europe) Major Business
2.6.3 GlaxoSmithKline (Europe) Influenza Vaccination Product and Solutions
2.6.4 GlaxoSmithKline (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 GlaxoSmithKline (Europe) Recent Developments and Future Plans
2.7 Hualan Biological Engineering (Asia Pacific)
2.7.1 Hualan Biological Engineering (Asia Pacific) Details
2.7.2 Hualan Biological Engineering (Asia Pacific) Major Business
2.7.3 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product and Solutions
2.7.4 Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Hualan Biological Engineering (Asia Pacific) Recent Developments and Future Plans
2.8 Mitsubishi Tanabe Pharma (Asia Pacific)
2.8.1 Mitsubishi Tanabe Pharma (Asia Pacific) Details
2.8.2 Mitsubishi Tanabe Pharma (Asia Pacific) Major Business
2.8.3 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product and Solutions
2.8.4 Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments and Future Plans
2.9 F. Hoffmann-La Roche (Europe)
2.9.1 F. Hoffmann-La Roche (Europe) Details
2.9.2 F. Hoffmann-La Roche (Europe) Major Business
2.9.3 F. Hoffmann-La Roche (Europe) Influenza Vaccination Product and Solutions
2.9.4 F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 F. Hoffmann-La Roche (Europe) Recent Developments and Future Plans
2.10 Sanofi (Europe)
2.10.1 Sanofi (Europe) Details
2.10.2 Sanofi (Europe) Major Business
2.10.3 Sanofi (Europe) Influenza Vaccination Product and Solutions
2.10.4 Sanofi (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Sanofi (Europe) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Influenza Vaccination Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Influenza Vaccination Players Market Share in 2021
3.2.2 Top 10 Influenza Vaccination Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Influenza Vaccination Players Head Office, Products and Services Provided
3.4 Influenza Vaccination Mergers & Acquisitions
3.5 Influenza Vaccination New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Influenza Vaccination Revenue and Market Share by Type (2017-2022)
4.2 Global Influenza Vaccination Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Influenza Vaccination Revenue Market Share by Application (2017-2022)
5.2 Global Influenza Vaccination Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Influenza Vaccination Revenue by Type (2017-2028)
6.2 North America Influenza Vaccination Revenue by Application (2017-2028)
6.3 North America Influenza Vaccination Market Size by Country
6.3.1 North America Influenza Vaccination Revenue by Country (2017-2028)
6.3.2 United States Influenza Vaccination Market Size and Forecast (2017-2028)
6.3.3 Canada Influenza Vaccination Market Size and Forecast (2017-2028)
6.3.4 Mexico Influenza Vaccination Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Influenza Vaccination Revenue by Type (2017-2028)
7.2 Europe Influenza Vaccination Revenue by Application (2017-2028)
7.3 Europe Influenza Vaccination Market Size by Country
7.3.1 Europe Influenza Vaccination Revenue by Country (2017-2028)
7.3.2 Germany Influenza Vaccination Market Size and Forecast (2017-2028)
7.3.3 France Influenza Vaccination Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Influenza Vaccination Market Size and Forecast (2017-2028)
7.3.5 Russia Influenza Vaccination Market Size and Forecast (2017-2028)
7.3.6 Italy Influenza Vaccination Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Influenza Vaccination Revenue by Type (2017-2028)
8.2 Asia-Pacific Influenza Vaccination Revenue by Application (2017-2028)
8.3 Asia-Pacific Influenza Vaccination Market Size by Region
8.3.1 Asia-Pacific Influenza Vaccination Revenue by Region (2017-2028)
8.3.2 China Influenza Vaccination Market Size and Forecast (2017-2028)
8.3.3 Japan Influenza Vaccination Market Size and Forecast (2017-2028)
8.3.4 South Korea Influenza Vaccination Market Size and Forecast (2017-2028)
8.3.5 India Influenza Vaccination Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Influenza Vaccination Market Size and Forecast (2017-2028)
8.3.7 Australia Influenza Vaccination Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Influenza Vaccination Revenue by Type (2017-2028)
9.2 South America Influenza Vaccination Revenue by Application (2017-2028)
9.3 South America Influenza Vaccination Market Size by Country
9.3.1 South America Influenza Vaccination Revenue by Country (2017-2028)
9.3.2 Brazil Influenza Vaccination Market Size and Forecast (2017-2028)
9.3.3 Argentina Influenza Vaccination Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Influenza Vaccination Revenue by Type (2017-2028)
10.2 Middle East & Africa Influenza Vaccination Revenue by Application (2017-2028)
10.3 Middle East & Africa Influenza Vaccination Market Size by Country
10.3.1 Middle East & Africa Influenza Vaccination Revenue by Country (2017-2028)
10.3.2 Turkey Influenza Vaccination Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Influenza Vaccination Market Size and Forecast (2017-2028)
10.3.4 UAE Influenza Vaccination Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Influenza Vaccination Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Influenza Vaccination Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Influenza Vaccination Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Influenza Vaccination Revenue (USD Million) by Region (2017-2022)
Table 5. Global Influenza Vaccination Revenue Market Share by Region (2023-2028)
Table 6. Abbott (U.S.) Corporate Information, Head Office, and Major Competitors
Table 7. Abbott (U.S.) Major Business
Table 8. Abbott (U.S.) Influenza Vaccination Product and Solutions
Table 9. Abbott (U.S.) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AstraZeneca (Europe) Corporate Information, Head Office, and Major Competitors
Table 11. AstraZeneca (Europe) Major Business
Table 12. AstraZeneca (Europe) Influenza Vaccination Product and Solutions
Table 13. AstraZeneca (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. BioCryst Pharmaceuticals (U.S.) Corporate Information, Head Office, and Major Competitors
Table 15. BioCryst Pharmaceuticals (U.S.) Major Business
Table 16. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Product and Solutions
Table 17. BioCryst Pharmaceuticals (U.S.) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Novartis (Europe) Corporate Information, Head Office, and Major Competitors
Table 19. Novartis (Europe) Major Business
Table 20. Novartis (Europe) Influenza Vaccination Product and Solutions
Table 21. Novartis (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. DAIICHI SANKYO COMPANY (Asia Pacific) Corporate Information, Head Office, and Major Competitors
Table 23. DAIICHI SANKYO COMPANY (Asia Pacific) Major Business
Table 24. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Product and Solutions
Table 25. DAIICHI SANKYO COMPANY (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. GlaxoSmithKline (Europe) Corporate Information, Head Office, and Major Competitors
Table 27. GlaxoSmithKline (Europe) Major Business
Table 28. GlaxoSmithKline (Europe) Influenza Vaccination Product and Solutions
Table 29. GlaxoSmithKline (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Hualan Biological Engineering (Asia Pacific) Corporate Information, Head Office, and Major Competitors
Table 31. Hualan Biological Engineering (Asia Pacific) Major Business
Table 32. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Product and Solutions
Table 33. Hualan Biological Engineering (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Mitsubishi Tanabe Pharma (Asia Pacific) Corporate Information, Head Office, and Major Competitors
Table 35. Mitsubishi Tanabe Pharma (Asia Pacific) Major Business
Table 36. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Product and Solutions
Table 37. Mitsubishi Tanabe Pharma (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. F. Hoffmann-La Roche (Europe) Corporate Information, Head Office, and Major Competitors
Table 39. F. Hoffmann-La Roche (Europe) Major Business
Table 40. F. Hoffmann-La Roche (Europe) Influenza Vaccination Product and Solutions
Table 41. F. Hoffmann-La Roche (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Sanofi (Europe) Corporate Information, Head Office, and Major Competitors
Table 43. Sanofi (Europe) Major Business
Table 44. Sanofi (Europe) Influenza Vaccination Product and Solutions
Table 45. Sanofi (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Global Influenza Vaccination Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 47. Global Influenza Vaccination Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 48. Breakdown of Influenza Vaccination by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Influenza Vaccination Players Head Office, Products and Services Provided
Table 50. Influenza Vaccination Mergers & Acquisitions in the Past Five Years
Table 51. Influenza Vaccination New Entrants and Expansion Plans
Table 52. Global Influenza Vaccination Revenue (USD Million) by Type (2017-2022)
Table 53. Global Influenza Vaccination Revenue Share by Type (2017-2022)
Table 54. Global Influenza Vaccination Revenue Forecast by Type (2023-2028)
Table 55. Global Influenza Vaccination Revenue by Application (2017-2022)
Table 56. Global Influenza Vaccination Revenue Forecast by Application (2023-2028)
Table 57. North America Influenza Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 58. North America Influenza Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 59. North America Influenza Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 60. North America Influenza Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 61. North America Influenza Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 62. North America Influenza Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 63. Europe Influenza Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 64. Europe Influenza Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 65. Europe Influenza Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 66. Europe Influenza Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 67. Europe Influenza Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 68. Europe Influenza Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 69. Asia-Pacific Influenza Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 70. Asia-Pacific Influenza Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 71. Asia-Pacific Influenza Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 72. Asia-Pacific Influenza Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 73. Asia-Pacific Influenza Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 74. Asia-Pacific Influenza Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 75. South America Influenza Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 76. South America Influenza Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 77. South America Influenza Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 78. South America Influenza Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 79. South America Influenza Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 80. South America Influenza Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 81. Middle East & Africa Influenza Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 82. Middle East & Africa Influenza Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 83. Middle East & Africa Influenza Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 84. Middle East & Africa Influenza Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 85. Middle East & Africa Influenza Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 86. Middle East & Africa Influenza Vaccination Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Influenza Vaccination Picture
Figure 2. Global Influenza Vaccination Revenue Market Share by Type in 2021
Figure 3. Egg Based
Figure 4. Cell Culture
Figure 5. Recombinant
Figure 6. Influenza Vaccination Revenue Market Share by Application in 2021
Figure 7. Hospitals Picture
Figure 8. Research Organizations Picture
Figure 9. Global Influenza Vaccination Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Influenza Vaccination Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Influenza Vaccination Revenue Market Share by Region (2017-2028)
Figure 12. Global Influenza Vaccination Revenue Market Share by Region in 2021
Figure 13. North America Influenza Vaccination Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Influenza Vaccination Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Influenza Vaccination Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Influenza Vaccination Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Influenza Vaccination Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Influenza Vaccination Market Drivers
Figure 19. Influenza Vaccination Market Restraints
Figure 20. Influenza Vaccination Market Trends
Figure 21. Abbott (U.S.) Recent Developments and Future Plans
Figure 22. AstraZeneca (Europe) Recent Developments and Future Plans
Figure 23. BioCryst Pharmaceuticals (U.S.) Recent Developments and Future Plans
Figure 24. Novartis (Europe) Recent Developments and Future Plans
Figure 25. DAIICHI SANKYO COMPANY (Asia Pacific) Recent Developments and Future Plans
Figure 26. GlaxoSmithKline (Europe) Recent Developments and Future Plans
Figure 27. Hualan Biological Engineering (Asia Pacific) Recent Developments and Future Plans
Figure 28. Mitsubishi Tanabe Pharma (Asia Pacific) Recent Developments and Future Plans
Figure 29. F. Hoffmann-La Roche (Europe) Recent Developments and Future Plans
Figure 30. Sanofi (Europe) Recent Developments and Future Plans
Figure 31. Global Influenza Vaccination Revenue Share by Players in 2021
Figure 32. Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 33. Global Top 3 Players Influenza Vaccination Revenue Market Share in 2021
Figure 34. Global Top 10 Players Influenza Vaccination Revenue Market Share in 2021
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 36. Global Influenza Vaccination Revenue Share by Type in 2021
Figure 37. Global Influenza Vaccination Market Share Forecast by Type (2023-2028)
Figure 38. Global Influenza Vaccination Revenue Share by Application in 2021
Figure 39. Global Influenza Vaccination Market Share Forecast by Application (2023-2028)
Figure 40. North America Influenza Vaccination Sales Market Share by Type (2017-2028)
Figure 41. North America Influenza Vaccination Sales Market Share by Application (2017-2028)
Figure 42. North America Influenza Vaccination Revenue Market Share by Country (2017-2028)
Figure 43. United States Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Influenza Vaccination Sales Market Share by Type (2017-2028)
Figure 47. Europe Influenza Vaccination Sales Market Share by Application (2017-2028)
Figure 48. Europe Influenza Vaccination Revenue Market Share by Country (2017-2028)
Figure 49. Germany Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Influenza Vaccination Sales Market Share by Type (2017-2028)
Figure 55. Asia-Pacific Influenza Vaccination Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Influenza Vaccination Revenue Market Share by Region (2017-2028)
Figure 57. China Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. South Korea Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Influenza Vaccination Sales Market Share by Type (2017-2028)
Figure 64. South America Influenza Vaccination Sales Market Share by Application (2017-2028)
Figure 65. South America Influenza Vaccination Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East and Africa Influenza Vaccination Sales Market Share by Type (2017-2028)
Figure 69. Middle East and Africa Influenza Vaccination Sales Market Share by Application (2017-2028)
Figure 70. Middle East and Africa Influenza Vaccination Revenue Market Share by Country (2017-2028)
Figure 71. Turkey Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Saudi Arabia Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. UAE Influenza Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
